There are concerns about the effectiveness of COVID-19 vaccines against immune escape by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants of concern (VOCs). Delta is currently the ...

An engineered CRISPR-based method that finds RNA from SARS-CoV-2, the virus that causes COVID-19, promises to make testing for that and other diseases fast and easy, researchers report. The ...

In a recent study posted to the medRxiv* pre-print server, a team of researchers performed an observational study to understand the effects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV ...

Since its emergence as a novel pandemic in 2019, SARS-CoV-2 has become endemic worldwide. Accordingly, there is an ongoing market in antigen-based testing for this virus. Microbix's SARS-CoV-2 antigen ...

Voluntary SARS CoV 2 testing of the hemodialysis population may require incentives beyond varying test frequency. Only 8% of patients voluntarily comply with repeat SARS-CoV-2 testing in hemodialysis ...

The review by Drain (Jan. 20 issue) 1 about rapid diagnostic testing for SARS-CoV-2 raises important questions. First, Drain states that persons who are not fully vaccinated and who have had exposure ...

CARLSBAD, Calif., March 19, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ:GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the ...

LUXEMBOURG--(BUSINESS WIRE)--Eurofins Environment Testing adds Omicron variant detection capabilities to its commercially available SARS-CoV-2 test portfolio. The Omicron variant has been identified ...